MedTrace Logo

Safety and Efficacy Study in Subjects With Seborrheic Dermatitis

NCT01703793 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2013-01-09

No results posted yet for this study

Summary

The purpose of this study is to determine if two test products are safe and effective in the treatment of seborrheic dermatitis.

Conditions

  • Seborrheic Dermatitis

Interventions

DRUG

Test Product 49778

DRUG

Test Product 10156

DRUG

Vehicle (placebo)

Sponsors & Collaborators

  • Medicis Global Service Corporation

    lead INDUSTRY

Principal Investigators

  • Ira Lawrence, MD · Medicis Pharmaceutical

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01703793 on ClinicalTrials.gov